Foreign & Colonial reports double digit growth in NAV per share

Net asset value per share rose 10.8 per cent to 357.60p while the net asset value total return was 13.3 per cent at Foreign & Colonial Investments (F&C) in the year ended December 31st.

Net asset value per share rose 10.8 per cent to 357.60p while the net asset value total return was 13.3 per cent at Foreign & Colonial Investments (F&C) in the year ended December 31st.

The company's annual dividend per share rose 19.7% to 8.50p prompting the share price to rise more than 11%.

Simon Fraser, the Chairman of F&C, said: "All major stock markets rose in the year despite slower than expected economic growth, political uncertainty in many countries and sluggish earnings growth from many companies. Central banks continued to find new ways of injecting money into the financial system and none of the potential disasters investors were worried about occurred by the end of the year."

"The biggest positive influences on our performance in the year were strong stock selection overseas and our relatively high level of gearing in rising markets. Our private equity portfolio generated far more cash than in 2011 but did not rise as much as public markets."

He added: "Our performance in 2012 continued our record of long-term growth. Over the last ten years we have achieved a total return of 9.5% per annum compared with a benchmark return of 8.6% per annum. At the same time our NAV has been less volatile than the index benchmark. In short we have produced superior performance with lower risk."

F&C's share price was down 0.17% to 352.40p at 08:46 on Monday.

MF

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

Barry Norris: we’re already in the 1970s. Here’s how to invest
Investment strategy

Barry Norris: we’re already in the 1970s. Here’s how to invest

Merryn talks to Barry Norris of Argonaut capital about the parallels between now and the 1970s; the transition to “green” energy; and the one sector w…
19 May 2022
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022